Illumina seeks cut of bioinformatics biz with cloud system
Grazed from FierceBioIT. Author: Ryan McBride.
As promised, Illumina ($ILMN) has hit the market with a cloud computing system for genomics data, building off its leadership in DNA sequencing to grab a piece of the growing bioinformatics side of the genomics game. And the San Diego-based company wants to make the decision to use to its BaseSpace computing product an easy one: Customers get 1 terabyte of free storage and variant analysis and sequence alignment for all data from the company’s sequencers at no cost.
Computer science has grown in importance to understanding decoded genomes. Illumina has helped drive down the cost of decoding the 3 billion bases of human DNA, rapidly closing in on $1,000 per genome, putting the technology within reach for hospitals and labs that might not have bothered 5 years or so ago when that price tag was in the millions. But labs can spend many times more than the cost of sequencing a genome to interpret the huge amounts of information from decoding DNA, with powerful computers and software analytics consuming much of that additional cost. BaseSpace also puts the data in the cloud, enabling people in different locations to share the information more easily than shipping it from one place to another…

